Predicting H5N1 disease severity based on T cell responses

New research led by scientists at La Jolla Institute for Immunology (LJI) suggests that many people already have immune cells on “stand by” to fight the H5N1 virus, also known as highly pathogenic avian influenza.

Early Assessment Fairly Accurate for Flagging Cerebral Palsy

Early neurodevelopmental assessments effectively identified infants with cerebral palsy and predicted its severity in extremely small or preterm infants and those with encephalopathy, according to

May 7, 2024

Intellia plays down concerns about accidental germline transmission in CRISPR trial

Earlier this month, Intellia Therapeutics announced it was scrapping plans to include U.S.-based sites in one of its mid-stage CRISPR trials after the Food and

August 21, 2023

Pharmalittle: We’re reading about Sanders targeting pharma CEOs, insider trading, and more

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

January 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.